Catherine Novack
Stock Analyst at Jones Trading
(n/a)
# 3,851
Out of 4,829 analysts
19
Total ratings
n/a
Success rate
-41.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGLS Regulus Therapeutics | Downgrades: Hold | $8 → $7 | $7.86 | -10.94% | 2 | Apr 30, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.30 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $20.85 | +115.83% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.61 | +583.23% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $16.01 | +711.99% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $7.10 | +463.38% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.38 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.64 | +140.96% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $2.08 | +574.70% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $2.88 | +351.39% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.72 | +169.18% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.07 | +838.97% | 1 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.99 | +1,005.53% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.30 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.24 | +7,047.00% | 1 | Jul 21, 2023 |
Regulus Therapeutics
Apr 30, 2025
Downgrades: Hold
Price Target: $8 → $7
Current: $7.86
Upside: -10.94%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $20.85
Upside: +115.83%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.61
Upside: +583.23%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $16.01
Upside: +711.99%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $7.10
Upside: +463.38%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.38
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.64
Upside: +140.96%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $2.08
Upside: +574.70%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.88
Upside: +351.39%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.72
Upside: +169.18%
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.07
Upside: +838.97%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.99
Upside: +1,005.53%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.30
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.24
Upside: +7,047.00%